Obesity
Susan Zelitch Yanovski, Jack Adam Yanovski · New England Journal of Medicine · 2002
The most common nutritional disorders in the United States are overweight and obesity. This review discusses the treatment of overweight and obesity as chronic conditions that require a combined approach of behavioral therapy, exercise, dietary changes, and — in certain cases — medication. The authors consider the three classes of weight-loss drugs: those that suppress appetite, those that decrease nutrient absorption, and those that increase energy expenditure. Currently available and soon-to-be-released drugs are discussed.
Cited by 544 works. doi:10.1056/nejmra012586
Authors
References
- Weight-Reducing Effects of the Plasma Protein Encoded by the obese Gene
- Overweight and obesity in the United States: prevalence and trends, 1960–1994
- Overweight Prevalence and Trends for Children and Adolescents
- Congenital leptin deficiency is associated with severe early-onset obesity in humans
- Valvular Heart Disease Associated with Fenfluramine–Phentermine
- Metformin
- Overweight, Obesity, and Health Risk
- Efficacy of Metformin in Patients with Non-Insulin-Dependent Diabetes Mellitus
- Executive Summary
- Effects of Recombinant Leptin Therapy in a Child with Congenital Leptin Deficiency